Evofem Biosciences (EVFM) has released an update to notify the public and investors about an entry into a material definitive agreement.
Evofem Biosciences, Inc. has entered into a Merger Agreement with Aditxt, Inc. and its subsidiary, which has been amended twice, altering the timelines for a joint proxy statement and a Parent Loan to the Company. The Company will file a proxy statement to provide stockholders with essential information regarding the proposed Merger, and stockholders are urged to read these documents before voting. The directors and executive officers of the Company may be participants in the solicitation of proxies for the upcoming meeting to approve the Merger.
For further insights into EVFM stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
